INSP Relative Valuation
INSP's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, INSP is overvalued; if below, it's undervalued.
Historical Valuation
Inspire Medical Systems Inc (INSP) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 5.27. The fair price of Inspire Medical Systems Inc (INSP) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：140.03
Fair
85.42
PE
1Y
3Y
5Y
Trailing
Forward
19.21
EV/EBITDA
Inspire Medical Systems Inc. (INSP) has a current EV/EBITDA of 19.21. The 5-year average EV/EBITDA is -31.42. The thresholds are as follows: Strongly Undervalued below -376.41, Undervalued between -376.41 and -203.92, Fairly Valued between 141.08 and -203.92, Overvalued between 141.08 and 313.57, and Strongly Overvalued above 313.57. The current Forward EV/EBITDA of 19.21 falls within the Historic Trend Line -Fairly Valued range.
99.67
EV/EBIT
Inspire Medical Systems Inc. (INSP) has a current EV/EBIT of 99.67. The 5-year average EV/EBIT is 17.83. The thresholds are as follows: Strongly Undervalued below -587.45, Undervalued between -587.45 and -284.81, Fairly Valued between 320.47 and -284.81, Overvalued between 320.47 and 623.11, and Strongly Overvalued above 623.11. The current Forward EV/EBIT of 99.67 falls within the Historic Trend Line -Fairly Valued range.
4.04
PS
Inspire Medical Systems Inc. (INSP) has a current PS of 4.04. The 5-year average PS is 12.35. The thresholds are as follows: Strongly Undervalued below -2.91, Undervalued between -2.91 and 4.72, Fairly Valued between 19.98 and 4.72, Overvalued between 19.98 and 27.61, and Strongly Overvalued above 27.61. The current Forward PS of 4.04 falls within the Undervalued range.
21.72
P/OCF
Inspire Medical Systems Inc. (INSP) has a current P/OCF of 21.72. The 5-year average P/OCF is -80.57. The thresholds are as follows: Strongly Undervalued below -534.50, Undervalued between -534.50 and -307.53, Fairly Valued between 146.39 and -307.53, Overvalued between 146.39 and 373.35, and Strongly Overvalued above 373.35. The current Forward P/OCF of 21.72 falls within the Historic Trend Line -Fairly Valued range.
24.45
P/FCF
Inspire Medical Systems Inc. (INSP) has a current P/FCF of 24.45. The 5-year average P/FCF is -23.15. The thresholds are as follows: Strongly Undervalued below -473.48, Undervalued between -473.48 and -248.31, Fairly Valued between 202.02 and -248.31, Overvalued between 202.02 and 427.19, and Strongly Overvalued above 427.19. The current Forward P/FCF of 24.45 falls within the Historic Trend Line -Fairly Valued range.
Inspire Medical Systems Inc (INSP) has a current Price-to-Book (P/B) ratio of 6.10. Compared to its 3-year average P/B ratio of 9.71 , the current P/B ratio is approximately -37.12% higher. Relative to its 5-year average P/B ratio of 15.72, the current P/B ratio is about -61.17% higher. Inspire Medical Systems Inc (INSP) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 0.82%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 0.25% , the current FCF yield is about -100.00% lower.
6.10
P/B
Median3y
9.71
Median5y
15.72
2.52
FCF Yield
Median3y
0.82
Median5y
0.25
Competitors Valuation Multiple
The average P/S ratio for INSP's competitors is , providing a benchmark for relative valuation. Inspire Medical Systems Inc Corp (INSP) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 10.49%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of INSP decreased by 24.46% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 81.44 to 94.86.
The secondary factor is the Revenue Growth, contributed 10.49%to the performance.
Overall, the performance of INSP in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Inspire Medical Systems Inc (INSP) currently overvalued or undervalued?
What is Inspire Medical Systems Inc (INSP) fair value?
How does INSP's valuation metrics compare to the industry average?
What is the current P/B ratio for Inspire Medical Systems Inc (INSP) as of Dec 05 2025?
What is the current FCF Yield for Inspire Medical Systems Inc (INSP) as of Dec 05 2025?
What is the current Forward P/E ratio for Inspire Medical Systems Inc (INSP) as of Dec 05 2025?